Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Opioid-Related Disorders

3,4-methylenedioxyamphetamine has been researched along with Opioid-Related Disorders in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Opioid-Related Disorders: Disorders related to or resulting from abuse or misuse of OPIOIDS.

Research Excerpts

ExcerptRelevanceReference
" The statistical distribution of the drug concentrations compared with the self-reported consumption behaviour of the users may possibly lead to a better understanding of the relationship between drug dosage and corresponding concentrations in hair."1.29Concentrations of delta 9-tetrahydrocannabinol, cocaine and 6-monoacetylmorphine in hair of drug abusers. ( Kauert, G; Röhrich, J, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kauert, G1
Röhrich, J1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Opioid-Related Disorders

ArticleYear
Concentrations of delta 9-tetrahydrocannabinol, cocaine and 6-monoacetylmorphine in hair of drug abusers.
    International journal of legal medicine, 1996, Volume: 108, Issue:6

    Topics: 3,4-Methylenedioxyamphetamine; Accidents, Traffic; Amphetamine; Cocaine; Crime; Designer Drugs; Dron

1996